FDA inspection
Vimta Labs, Limited: FDA inspection ending Jan 12, 2023
FDA inspection 1194741 · No Action Indicated (NAI) · Hyderabad
Key facts
| Inspection ID | 1194741 |
|---|---|
| Firm | Vimta Labs, Limited |
| FEI number | 3005580517 |
| Address | 142 Ida Phase II |
| City | Hyderabad |
| Country | India |
| Fiscal year | 2023 |
| Inspection end date | Jan 12, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data